Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma
Virchows Archiv Dec 13, 2019
Petrova E, Zielinski V, Bolm L, et al. - In total, 119 individuals resected for pancreatic ductal carcinoma from 1996 to 2015 were involved in this retrospective study in order to examine the relationship between tumor budding and perineural invasion and their prognostic role in pancreatic ductal adenocarcinoma. In the univariable Cox regression, despite the quantification strategy, high tumor budding was an important negative prognostic factor. In the multivariable model adjusting for stage and standard histopathological parameters, independent negative prognostic factors were lymph vessel invasion and tumor budding > 5 buds/0.237 mm2, whilst a positive prognostic factor was an adjuvant therapy. For the perineural invasion, no important prognostic value could be described. In summary, in pancreatic ductal adenocarcinoma related to lymph node metastasis, tumor budding is an independent negative prognostic factor. However, the prognostic role of perineural invasion continues to be unclear.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries